Cargando…
EHMT2 Inhibition Induces Cell Death in Human Non-Small Cell Lung Cancer by Altering the Cholesterol Biosynthesis Pathway
Non-small cell lung cancer (NSCLC) is a major subtype of lung cancer. Besides genetic and environmental factors, epigenetic alterations contribute to the tumorigenesis of NSCLC. Epigenetic changes are considered key drivers of cancer initiation and progression, and altered expression and activity of...
Autores principales: | Kim, Haeun, Choi, Seo Yoon, Lim, Jinyeong, Lindroth, Anders M., Park, Yoon Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037906/ https://www.ncbi.nlm.nih.gov/pubmed/32028644 http://dx.doi.org/10.3390/ijms21031002 |
Ejemplares similares
-
Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy
por: Kang, Zhihua, et al.
Publicado: (2023) -
EHMT2/G9a Inhibits Aortic Smooth Muscle Cell Death by Suppressing Autophagy Activation
por: Chen, Tai-Qiang, et al.
Publicado: (2020) -
Analogues of the natural product Sinefungin as potent inhibitors of EHMT1 and EHMT2
por: Devkota, Kanchan, et al.
Publicado: (2013) -
Neuroprotective effects of Paeonia Lactiflora extract against cell death of dopaminergic SH-SY5Y cells is mediated by epigenetic modulation
por: Lee, Gyuhwi, et al.
Publicado: (2016) -
Links between Serine Biosynthesis Pathway and Epigenetics in Cancer Metabolism
por: Kim, HaEun, et al.
Publicado: (2018)